|
|
Volumn 29, Issue 12, 2001, Pages 19-26
|
|
Metabolic syndromes associated with HIV: Mitigating the side effects of drug therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
AMPRENAVIR;
ANABOLIC AGENT;
ANTILIPEMIC AGENT;
ANTIRETROVIRUS AGENT;
ATORVASTATIN;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
FIBRIC ACID DERIVATIVE;
GEMFIBROZIL;
HUMAN GROWTH HORMONE;
INDINAVIR;
LACTIC ACID;
LAMIVUDINE;
LIPID;
NELFINAVIR;
NEVIRAPINE;
OXANDROLONE;
PRAVASTATIN;
RITONAVIR;
SAQUINAVIR;
SIMVASTATIN;
SOMATOMEDIN C;
STATINE DERIVATIVE;
STAVUDINE;
TESTOSTERONE;
UNINDEXED DRUG;
ZALCITABINE;
ZIDOVUDINE;
ANEMIA;
BLOOD PRESSURE REGULATION;
CACHEXIA;
CLINICAL FEATURE;
DIABETES MELLITUS;
DIET;
EXERCISE;
FATTY LIVER;
GASTROINTESTINAL TOXICITY;
GLUCOSE INTOLERANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
LACTIC ACIDOSIS;
LIPODYSTROPHY;
LONG TERM CARE;
METABOLIC DISORDER;
MUSCLE ATROPHY;
NEPHROTOXICITY;
NEUROTOXICITY;
RASH;
REVIEW;
SMOKING CESSATION;
WASTING SYNDROME;
|
|
EID: 0035664411
PISSN: 00913847
EISSN: None
Source Type: Journal
DOI: 10.3810/psm.2001.12.1070 Document Type: Review |
|
Times cited : (3)
|
|
References (10)
|
